Guilhaumou, R.; Chevrier, C.; Setti, J.L.; Jouve, E.; Marsot, A.; Julian, N.; Blin, O.; Simeone, P.; Lagier, D.; Mokart, D.;
et al. β-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study. Antibiotics 2023, 12, 1289.
https://doi.org/10.3390/antibiotics12081289
AMA Style
Guilhaumou R, Chevrier C, Setti JL, Jouve E, Marsot A, Julian N, Blin O, Simeone P, Lagier D, Mokart D,
et al. β-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study. Antibiotics. 2023; 12(8):1289.
https://doi.org/10.3390/antibiotics12081289
Chicago/Turabian Style
Guilhaumou, Romain, Constance Chevrier, Jean Loup Setti, Elisabeth Jouve, Amélie Marsot, Nathan Julian, Olivier Blin, Pierre Simeone, David Lagier, Djamel Mokart,
and et al. 2023. "β-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study" Antibiotics 12, no. 8: 1289.
https://doi.org/10.3390/antibiotics12081289
APA Style
Guilhaumou, R., Chevrier, C., Setti, J. L., Jouve, E., Marsot, A., Julian, N., Blin, O., Simeone, P., Lagier, D., Mokart, D., Bruder, N., Garnier, M., & Velly, L.
(2023). β-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study. Antibiotics, 12(8), 1289.
https://doi.org/10.3390/antibiotics12081289